Clinical Trial Update: Intracoronary Injection of Autologous Bone Marrow Cells in Patients With Chronic Heart Failure: Five Years Follow up [Phase 2]

View source ↗

Summary

Five-year follow-up results from a Phase 2 trial evaluating intracoronary injection of autologous bone marrow cells in patients with chronic ischemic symptomati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Failure

Drugs mentioned

• Autologous bone marrow cell therapy (Autologous bone marrow cells)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Chronic Ischemic Symptomatic Heart Failure | Phase 2 | Status: COMPLETED